Michael Benedick, Author at Blue Link

About Michael Benedick

Michael Benedick is a Sr. Salesperson at Blue Link Associates. As one of Blue Link’s product experts, he has extensive knowledge of the software and has worked with wholesale and distribution companies in many industries. A serious golf fanatic, Michael can be found at a golf course on most weekends.

What You Missed at the 2018 HDA Traceability Seminar: Important DSCSA Guidance

Disclaimer: The information and opinions expressed in this blog are based on the author’s best understanding of the updates from HDA’s 2018 Traceability Seminar and do not necessarily reflect the official policies or opinions of the industry in who[...]
By |Tags: , |

HDA’s Traceability Seminar Key Takeaways —What Pharmaceutical Distributors Need to Know

Disclaimer: The information and opinions expressed in this blog are based on the authors best understanding of the updates from HDA’s 2017 Traceability Seminar and do not necessarily reflect the official policies or opinions of the industry in wh[...]
By |

How to Manage DSCSA Requirements with Pharmaceutical Software

This post is Part 6 and the last post of the Series: Understanding The DSCSA and What it Means for Pharmaceutical Distribution Companies. To read the first 5 parts of the Series, visit the links at the end of this post.   In November 2013, former [...]
By |

Drug Supply Chain Security Act (DSCSA) – Annual Reporting

This post is Part 5 of the Series: Understanding The DSCSA and What it Means for Pharmaceutical Distribution Companies.  Click here for Part 1, Click here for Part 2, Click here for Part 3 and Click here for Part 4.  The DSCSA outlines specific[...]
By |

Serialized Numerical Identifier (SNI) and the Drug Supply Chain Security Act

This post is Part 4 of the Series: Understanding The DSCSA and What it Means for Pharmaceutical Distribution Companies.  Click here for Part 1, Click here for Part 2 and Click here for Part 3. One of the key requirements as part of the Drug Suppl[...]

DSCSA: Suspect and Illegitimate Product Handling and Notification

This post is Part 3 of the Series: Understanding The Drug Supply Chain Security Act and What it Means for Pharmaceutical Distribution Companies. Click here for Part 1 and click here for Part 2.  As discussed previously, one of the main reasons for[...]
By |

Drug Supply Chain Security Act (DSCSA) Transaction Report (T3)

This post is Part 2 of the Series: Understanding The Drug Supply Chain Security Act and What it Means for Pharmaceutical Distribution Companies. Click here for Part 1.  The requirement to track products is not new to the pharmaceutical industry. [...]
By |

Drug Supply Chain Security Act (DSCSA) and Pharmaceutical Distribution

This post is Part 1 of the Series: Understanding The Drug Supply Chain Security Act and What it Means for Pharmaceutical Distribution Companies.   If you’ve had any association with the pharmaceutical industry over the past 2-3 years, it wou[...]
By |

Pharmaceutical Accounting Software for Start-Up Distribution Companies

If you want to start a pharmaceutical distribution business you must first purchase a license to sell product.  After you’ve acquired your licenses, you are then responsible for following specific guidelines in accordance with industry regulations arou[...]
By |

Business Management Software: When to Ask for Customer References

With any major purchase it is good practice to evaluate reviews and speak to references whenever possible. This is especially the case with any major business purchase, such as business management software. When searching for a new system, it is best to n[...]
By |Tags: |
Menu